Clinical Trial Update: A Study of LY3971297 in Participants With Heart Failure [Phase 1]

View source ↗

Summary

Phase 1 study of LY3971297 in participants with heart failure (including diastolic and systolic subtypes) is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Heart Failure with Preserved Ejection Fraction
• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• LY3971297

Snippet

Sponsor: Eli Lilly and Company | Conditions: Heart Failure, Heart Failure, Diastolic | Phase 1 | Status: NOT_YET_RECRUITING